Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Gaush MeditechHKSE:02407 +1.42%67 Operating Margin % is 10.14% as of Dec. 2025, which is 49% below its 10-year median of 19.85. GuruFocus rates HKSE:02407 with a GF Score™ of 67/100 and a GF Value™ of HK$13.40 (Possible Value Trap). The stock has 3 warning signs investors should review. Among 815 Medical Devices & Instruments companies, Gaush Meditech ranks better than 67.12% on this metric.
Gaush Meditech Ltd operating margin has been in a 5-year decline. The average rate of decline per year is -11.8%.
The historical rank and industry rank for Gaush Meditech's Operating Margin % or its related term are showing as below:
HKSE:02407'
s Operating Margin % Range Over the Past 10 Years
Min: 10.51 Med: 19.85 Max: 21.48
Current: 10.51
HKSE:02407's Operating Margin % is ranked better than 67.12% of 815
companies
in the Medical Devices & Instruments industry
Industry Median: 3.17
vs HKSE:02407: 10.51
Gaush Meditech's 5-Year Average Operating Margin % Growth Rate was -11.80% per year.
Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.
Be Aware
Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).
If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.
For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokias Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).
Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.
Gaush Meditech Operating Margin % Related Terms
Gaush Meditech Operating Margin % Historical Data
* Premium members only.
The historical data trend for Gaush Meditech's Operating Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HKSE:02407 vs ABT, SYK, MDT: Operating Margin % Comparison
For the Medical Devices subindustry, Gaush Meditech's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Gaush Meditech Operating Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Gaush Meditech's Operating Margin % distribution charts can be found below:
* The bar in red indicates where Gaush Meditech's Operating Margin % falls into.
Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.
Gaush Meditech's Operating Margin % for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Gaush Meditech (HKSE:02407) has a Operating Margin % of 10.14% as of Dec. 2025. Operating margin is the ratio of total operating income to net sales. View historical data on Gaush Meditech and its competitors. This is 49% below median its historical median of 19.85. Over the past decade, Gaush Meditech's Operating Margin % has ranged from 10.51 to 21.48. According to the industry distribution chart, Gaush Meditech ranks #268 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 32.9%.
Is Gaush Meditech's Operating Margin % too high?
Gaush Meditech's current Operating Margin % of 10.14% is 49% below median its 10-year median of 19.85. Over the past 10 years, this metric has ranged from a low of 10.51 to a high of 21.48. The Medical Devices & Instruments industry median Operating Margin % is 3.17. Gaush Meditech's value of 10.14% is 219.9% above this industry median. Based on the distribution chart, Gaush Meditech ranks #268 out of 815 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Gaush Meditech has a GF Score™ of 67/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Gaush Meditech's Operating Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Gaush Meditech ranks #268 out of 815 companies for Operating Margin %. This puts Gaush Meditech in the upper half of its industry. The industry median Operating Margin % is 3.17. Gaush Meditech's value of 10.14% is 219.9% above this benchmark. Historically, Gaush Meditech's own Operating Margin % has ranged from 10.51 to 21.48 over the past decade. While the company's 10-year median is 19.85 vs. the industry median of 3.17, Gaush Meditech has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Margin % for a Medical Devices & Instruments company?
The median Operating Margin % among Medical Devices & Instruments companies is 3.17, based on 815 companies in the industry. Companies in the top quartile (top 25%) have a Operating Margin % significantly above this median, while those in the bottom quartile fall well below. However, Operating Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Gaush Meditech's current Operating Margin % of 10.14% is 219.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Margin % mean?
A high Operating Margin % can signal that a stock is expensive relative to its fundamentals. Operating margin is the ratio of total operating income to net sales. View historical data on Gaush Meditech and its competitors. For the Medical Devices & Instruments industry, the median Operating Margin % is 3.17 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Gaush Meditech's current Operating Margin % is 10.14%, which is 49% below median its own 10-year median of 19.85. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gaush Meditech stock overvalued right now?
Based on GuruFocus' analysis, Gaush Meditech (HKSE:02407) is currently considered Possible Value Trap. The stock's GF Value™ is HK$13.40, compared to a current price of HK$5.00 — trading 62.7% below its estimated fair value. The current Operating Margin % is 10.14%, which is 49% below median its 10-year median of 19.85 and 219.9% above the Medical Devices & Instruments industry median of 3.17. Gaush Meditech's overall GF Score™ is 67/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Margin % calculated?
Operating Margin % is calculated from a company's financial statements. For Gaush Meditech (HKSE:02407), the current Operating Margin % is 10.14% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Gaush Meditech (HKSE:02407) Overvalued in 2026?
Based on GuruFocus' analysis, Gaush Meditech stock appears to be undervalued.
The current stock price of HK$5.00 is trading 62.7% below its estimated GF Value™ of HK$13.40.
GuruFocus considers Gaush Meditech to be Possible Value Trap.
Key valuation signals for HKSE:02407:
Operating Margin %: 10.14% (49% below median its 10-year median of 19.85)
GF Value™: HK$13.40 vs. price of HK$5.00 (62.7% below fair value)
Industry Position: 219.9% above the Medical Devices & Instruments median (#268 of 815)
No single metric tells the full story. See the HKSE:02407 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Gaush Meditech Ltd is a provider of a broad spectrum of manufacture and sale ophthalmic medical devices and provision of technical services. The segments of the company include Proprietary products segment that derives maximum revenue, develops and produces surgical equipment and related supporting software, intra-optical lens, ophthalmic disease diagnosis and treatment equipment and related supporting consumables independently; Distribution products segment sells multi-function diagnostic equipment, ocular fundus diagnosis, surgical and treatment equipment and related supporting consumables produced by ophthalmic medical equipment manufacturers; Technical services segment provides warranty services, maintenance services and other related consumables; and Others segment.
67GF Score
Get the complete analysis for HKSE:02407
Operating Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:02407 has been successfully added to your 
